
Over the last 7 days, the Life Sciences industry has dropped 2.1%, driven by a pullback from Shin Nippon Biomedical Laboratories of 4.1%. Meanwhile, Carna Biosciences actually outperformed within the industry, gaining 15% in the last week. The industry has fallen 5.6% in the last year. Looking forward, earnings are forecast to grow by 17% annually.
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 07 Jan 2026 | JP¥150.3b | JP¥66.9b | JP¥72.2m | 21.6x | 2082.8x | 2.2x |
| Fri, 05 Dec 2025 | JP¥156.1b | JP¥67.6b | JP¥702.4m | 17.7x | 222.3x | 2.3x |
| Sun, 02 Nov 2025 | JP¥132.2b | JP¥66.5b | JP¥1.5b | 15.9x | 90.6x | 2x |
| Tue, 30 Sep 2025 | JP¥146.9b | JP¥66.5b | JP¥1.5b | 17x | 100.7x | 2.2x |
| Thu, 28 Aug 2025 | JP¥145.9b | JP¥66.5b | JP¥1.5b | 16.9x | 100x | 2.2x |
| Sat, 26 Jul 2025 | JP¥140.6b | JP¥66.0b | JP¥1.1b | 16.6x | 124.6x | 2.1x |
| Mon, 23 Jun 2025 | JP¥139.8b | JP¥66.0b | JP¥1.1b | 16.6x | 123.4x | 2.1x |
| Wed, 21 May 2025 | JP¥133.2b | JP¥66.1b | JP¥1.4b | 13.6x | 92.6x | 2x |
| Fri, 18 Apr 2025 | JP¥128.3b | JP¥63.8b | JP¥963.0m | 13.8x | 133.2x | 2x |
| Sun, 16 Mar 2025 | JP¥162.8b | JP¥64.8b | JP¥927.4m | 15.5x | 175.5x | 2.5x |
| Tue, 11 Feb 2025 | JP¥173.7b | JP¥66.0b | JP¥1.6b | 15.9x | 109.7x | 2.6x |
| Thu, 09 Jan 2025 | JP¥165.9b | JP¥62.0b | JP¥440.7m | 17.9x | 376.4x | 2.7x |
| Sat, 07 Dec 2024 | JP¥163.1b | JP¥62.0b | JP¥825.9m | 16.9x | 197.5x | 2.6x |
| Mon, 04 Nov 2024 | JP¥149.8b | JP¥61.5b | JP¥1.8b | 21.2x | 81.3x | 2.4x |
| Wed, 02 Oct 2024 | JP¥156.8b | JP¥61.5b | JP¥1.8b | 17.9x | 85.2x | 2.6x |
| Fri, 30 Aug 2024 | JP¥166.3b | JP¥61.5b | JP¥2.1b | 20.2x | 78.9x | 2.7x |
| Sun, 28 Jul 2024 | JP¥162.5b | JP¥61.8b | JP¥3.2b | 24.9x | 50.2x | 2.6x |
| Tue, 25 Jun 2024 | JP¥163.3b | JP¥61.8b | JP¥3.2b | 26.3x | 50.5x | 2.6x |
| Thu, 23 May 2024 | JP¥161.4b | JP¥61.8b | JP¥3.4b | 24.6x | 48.2x | 2.6x |
| Sat, 20 Apr 2024 | JP¥181.7b | JP¥62.3b | JP¥3.3b | 14.3x | 55.2x | 2.9x |
| Mon, 18 Mar 2024 | JP¥227.6b | JP¥155.4b | JP¥8.6b | 13.8x | 26.4x | 1.5x |
| Wed, 14 Feb 2024 | JP¥234.0b | JP¥156.2b | JP¥9.0b | 14.5x | 25.9x | 1.5x |
| Fri, 12 Jan 2024 | JP¥233.6b | JP¥167.1b | JP¥8.5b | 16x | 27.5x | 1.4x |
| Sun, 10 Dec 2023 | JP¥227.6b | JP¥167.4b | JP¥8.7b | 14.5x | 26.2x | 1.4x |
| Tue, 07 Nov 2023 | JP¥235.7b | JP¥179.4b | JP¥12.9b | 14.6x | 18.3x | 1.3x |
| Thu, 05 Oct 2023 | JP¥248.2b | JP¥179.3b | JP¥12.8b | 14.9x | 19.4x | 1.4x |
| Sat, 02 Sep 2023 | JP¥268.1b | JP¥179.3b | JP¥12.8b | 17x | 21x | 1.5x |
| Mon, 31 Jul 2023 | JP¥268.7b | JP¥178.7b | JP¥15.7b | 16.1x | 17.2x | 1.5x |
| Wed, 28 Jun 2023 | JP¥277.3b | JP¥178.5b | JP¥16.2b | 17.4x | 17.1x | 1.6x |
| Fri, 26 May 2023 | JP¥278.7b | JP¥178.2b | JP¥15.9b | 15.7x | 17.5x | 1.6x |
| Sun, 23 Apr 2023 | JP¥285.9b | JP¥171.9b | JP¥13.3b | 16.5x | 21.5x | 1.7x |
| Tue, 21 Mar 2023 | JP¥302.6b | JP¥171.9b | JP¥13.3b | 16.2x | 22.8x | 1.8x |
| Thu, 16 Feb 2023 | JP¥301.5b | JP¥171.4b | JP¥12.8b | 18.2x | 23.6x | 1.8x |
| Sat, 14 Jan 2023 | JP¥292.9b | JP¥166.1b | JP¥16.2b | 14.8x | 18.1x | 1.8x |
18.1x
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 3.45% | |
| Healthcare | 1.49% | |
| Life Sciences | -0.56% | |
| Clinical Research and Equipment | -0.56% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4572 Carna Biosciences | JP¥404.00 | 13.5% +JP¥918.7m | 40.3% | PS14.2x | |
| 4880 CellSource | JP¥440.00 | 10.3% +JP¥812.7m | -49.0% | PE872.2x | |
| 4583 Chiome Bioscience | JP¥114.00 | 6.5% +JP¥476.3m | -54.4% | PS10.7x | |
| 7707 Precision System Science | JP¥201.00 | 8.1% +JP¥407.9m | -17.6% | PS1.1x | |
| 2183 Linical | JP¥311.00 | 6.1% +JP¥406.6m | -13.6% | PS0.7x |